Novel Orthogonally Hydrocarbon-Modified Cell-Penetrating Peptide Nanoparticles Mediate Efficient Delivery of Splice-Switching Antisense Oligonucleotides In Vitro and In Vivo
Safa Bazaz,
Tõnis Lehto,
Rahel Tops,
Olof Gissberg,
Dhanu Gupta,
Burcu Bestas,
Jeremy Bost,
Oscar P. B. Wiklander,
Helena Sork,
Eman M. Zaghloul,
Doste R. Mamand,
Mattias Hällbrink,
Rannar Sillard,
Osama Saher,
Kariem Ezzat,
C. I. Edvard Smith,
Samir EL Andaloussi,
Taavi Lehto
Affiliations
Safa Bazaz
Clinical Research Center, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, 14186 Huddinge, Sweden
Tõnis Lehto
Institute of Technology, University of Tartu, Nooruse 1, 50411 Tartu, Estonia
Rahel Tops
Institute of Technology, University of Tartu, Nooruse 1, 50411 Tartu, Estonia
Olof Gissberg
Clinical Research Center, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, 14186 Huddinge, Sweden
Dhanu Gupta
Clinical Research Center, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, 14186 Huddinge, Sweden
Burcu Bestas
Clinical Research Center, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, 14186 Huddinge, Sweden
Jeremy Bost
Clinical Research Center, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, 14186 Huddinge, Sweden
Oscar P. B. Wiklander
Clinical Research Center, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, 14186 Huddinge, Sweden
Helena Sork
Institute of Technology, University of Tartu, Nooruse 1, 50411 Tartu, Estonia
Eman M. Zaghloul
Clinical Research Center, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, 14186 Huddinge, Sweden
Doste R. Mamand
Clinical Research Center, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, 14186 Huddinge, Sweden
Mattias Hällbrink
Clinical Research Center, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, 14186 Huddinge, Sweden
Rannar Sillard
PeptiSystems AB, Virdings Allé 22, 75450 Uppsala, Sweden
Osama Saher
Clinical Research Center, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, 14186 Huddinge, Sweden
Kariem Ezzat
Clinical Research Center, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, 14186 Huddinge, Sweden
C. I. Edvard Smith
Clinical Research Center, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, 14186 Huddinge, Sweden
Samir EL Andaloussi
Clinical Research Center, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, 14186 Huddinge, Sweden
Taavi Lehto
Clinical Research Center, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, 14186 Huddinge, Sweden
Splice-switching therapy with splice-switching oligonucleotides (SSOs) has recently proven to be a clinically applicable strategy for the treatment of several mis-splice disorders. Despite this, wider application of SSOs is severely limited by the inherently poor bioavailability of SSO-based therapeutic compounds. Cell-penetrating peptides (CPPs) are a class of drug delivery systems (DDSs) that have recently gained considerable attention for improving the uptake of various oligonucleotide (ON)-based compounds, including SSOs. One strategy that has been successfully applied to develop effective CPP vectors is the introduction of various lipid modifications into the peptide. Here, we repurpose hydrocarbon-modified amino acids used in peptide stapling for the orthogonal introduction of hydrophobic modifications into the CPP structure during peptide synthesis. Our data show that α,α-disubstituted alkenyl-alanines can be successfully utilized to introduce hydrophobic modifications into CPPs to improve their ability to formulate SSOs into nanoparticles (NPs), and to mediate high delivery efficacy and tolerability both in vitro and in vivo. Conclusively, our results offer a new flexible approach for the sequence-specific introduction of hydrophobicity into the structure of CPPs and for improving their delivery properties.